With its existing entitlement, plus the newly acquired economics from BioInvent, XOMA Royalty will be entitled to milestones of up to USD $16.25 million from Takeda and mid-single digit royalties on ...

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

Biogen Inc. and City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced a strategic collaboration to develop ...

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

The Kiwi medical devices outfit has upped its full year revenue to a record NZ$2.2 billion and guides to a stronger result this year.

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

I n her State of the City address in March, Mayor Michelle Wu spoke about her then-2-month-old daughter. The world she ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

Alphabet will continue to maintain its leadership position when it comes to AI. Check out what underpins my bullish thesis ...

Thousands of unionized workers at Pratt & Whitney voted in favor of a new labor agreement, effectively ending a three-week ...